Dark
Light
Today: November 22, 2024
February 22, 2024
1 min read

Huge Success: HealthSnap Secures $25M in Series B Funding


TLDR:

HealthSnap, a provider of remote patient monitoring and chronic care management solutions, raised $25M in Series B funding led by Sands Capital. The total amount raised is now $48.5M, with new investments from Comcast Ventures, Acronym Venture Capital, and Florida Opportunity Fund. The company plans to use the funds to expand its clinical team, accelerate its product roadmap, and build its AI-powered population health and analytics solution. HealthSnap offers integrated virtual care management platforms to improve patient outcomes and reduce utilization.

Article Summary:

HealthSnap, a Miami-based provider of remote patient monitoring and chronic care management solutions, closed a $25M Series B funding round. This funding, led by Sands Capital, brought the total raised amount to $48.5M, with new investments from Comcast Ventures, Acronym Venture Capital, and Florida Opportunity Fund. Existing shareholders also participated in the round.

The company plans to use the funds to continue building its national clinical team, accelerate its product roadmap to meet market demand for care in the home, and begin developing its AI-powered population health and analytics solution. They are actively hiring for various positions to support their growth.

HealthSnap, led by CEO Samson Magid, offers an integrated virtual care management platform aimed at helping healthcare organizations improve patient outcomes, reduce utilization, and diversify revenue streams. They provide solutions for chronic disease-agnostic remote patient monitoring and chronic care management, AI-guided care coordination, virtual care delivery, patented billing tools, population analytics, and more.

In 2023, HealthSnap expanded its health system partnerships with UnityPoint Health and Prisma Health, showcasing improved clinical outcomes data across various chronic conditions like hypertension, heart failure, obesity, and Type 2 diabetes. The company continues to focus on innovative solutions to revolutionize remote patient monitoring and chronic care management in healthcare.


Previous Story

2024 Trends: Robotics & Automation Investment Insights

Next Story

TechCrunch Welcomes Bort: New VC/Startups Editor On Board

Latest from Blog

Go toTop